Reprint
Current Research on HIV Drug Resistance
Edited by
November 2022
152 pages
- ISBN978-3-0365-5511-9 (Hardback)
- ISBN978-3-0365-5512-6 (PDF)
This book is a reprint of the Special Issue Current Research on HIV Drug Resistance that was published in
Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare
Summary
HIV drug resistance is an unavoidable challenge for HIV/AIDS professionals, and it has long been a major obstacle hindering the global effort to contain HIV/AIDS. Pathogens journal launched a topical collection in 2021 on “Current Research on HIV Drug Resistance”, aiming to catch the latest advancements in HIV resistance diagnosis, surveillance and research. This book compiles all articles published in this collection, combining original research and review articles on HIV drug resistance.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
HIV drug resistance; sanger sequencing; next-generation sequencing; interrupted antiretroviral therapy; HIV-1; nef; Botswana; drug resistance mutations; 3′-polypurine tract; dolutegravir; HIV-1; single genome sequencing; drug resistance; integrase strand transfer inhibitors; replication fitness; case study; complex adaptive system; HIV drug resistance; leverage points; systems mapping; Dar es Salaam; Tanzania; HIV; drug resistance; surveillance; public health; Mexico; HIV pretreatment drug resistance; HIV acquired drug resistance; Mexico City; Mexico; HIV-1; antiviral therapy; drug resistance; protease inhibitor; protease; mutation; atazanavir; HIV; HCV; probe capture; enrichment; next-generation sequencing; HIV; drug resistance; point-of-care test; resource-limited setting; HIV; drug resistance; testing; analytes; specimens; performance; n/a